Li et al. (2017a) reported that 200 μg/kg irisin via the tail vein, given 30 minutes after middle cerebral artery occlusion (MCAO) to model stroke, decreased cerebral infarct volume 3 days later. The gene discussed is FNDC5; the disease is stroke disorder.